About Sepax Technologies
Sepax Technologies is a company based in Newark (United States) founded in 2002. Sepax Technologies has raised $109.24 million across 3 funding rounds from investors including Fosun, Gan & Lee Pharmaceutical and Sinopharm Capital. The company has 57 employees as of December 31, 2022. Sepax Technologies offers products and services including Proteomix HIC Butyl, Zenix-C SEC, Monomix TM MC SEC Resins, and Proteomix RP-1000. Sepax Technologies operates in a competitive market with competitors including ChromaTan, Upfront Chromatography, Natrix Separations, Reach Separations and PharmaFluidics, among others.
- Headquarter Newark, United States
- Employees 57 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sepax Technologies, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$109.24 M (USD)
in 3 rounds
-
Latest Funding Round
$78.36 M (USD), Series D
Nov 15, 2021
-
Investors
Fosun
& 7 more
-
Employee Count
57
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sepax Technologies
Sepax Technologies offers a comprehensive portfolio of products and services, including Proteomix HIC Butyl, Zenix-C SEC, Monomix TM MC SEC Resins, and Proteomix RP-1000.
Enables high-resolution hydrophobic interaction for biomolecules like mAbs.
Analyzes aggregates and fragments in antibody drug conjugates.
Provides stable SEC for broad pH ranges in protein purification.
Supports drug-to-antibody ratio analysis in ADCs.
People of Sepax Technologies
Unlock access to complete
Funding Insights of Sepax Technologies
Sepax Technologies has successfully raised a total of $109.24M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $78.36 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sepax Technologies
Sepax Technologies has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Fosun, Gan & Lee Pharmaceutical and Sinopharm Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Sepax Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sepax Technologies
Investment portfolio details for Sepax Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sepax Technologies
Detailed financials for Sepax Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sepax Technologies Comparisons
Peer comparison for Sepax Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sepax Technologies
Sepax Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Upfront Chromatography, Natrix Separations, Reach Separations and PharmaFluidics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| Locked | Locked | Locked |
Chromatography technologies for protein separation and biomolecule recovery are provided.
|
|
| Locked | Locked | Locked |
Provider of proprietary filtration solutions for life science
|
|
| Locked | Locked | Locked |
Small molecule analysis and purification services are provided using chromatography.
|
|
| Locked | Locked | Locked |
Microchip liquid chromatography cartridges are supplied for nano-LC applications.
|
Detailed competitors of Sepax Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sepax Technologies
Complete news archive for Sepax Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sepax Technologies
Sepax Technologies was founded in 2002 and raised its 1st funding round 16 years after it was founded.
Sepax Technologies is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.
Sepax Technologies is a funded company, having raised a total of $109.24M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Sepax Technologies is 57.
Sepax Technologies was founded in 2002 and is based in Newark, United States. Operations focus on the biotechnology sector, where products such as particle synthesis, surface modifications, LC column packing, and bulk media are produced for modalities including size exclusion, ion exchange, and reversed phase chromatography. Services encompass analytical chromatography, preparative purification, custom resins, and surface coatings, supporting biomolecular separation processes across various applications.
Sepax Technologies's top competitors include ChromaTan, Sepragen and Semba Biosciences.
Sepax Technologies offers Proteomix HIC Butyl, Zenix-C SEC, Monomix TM MC SEC Resins, and Proteomix RP-1000.
Sepax Technologies has 8 investors. Key investors include Fosun, Gan & Lee Pharmaceutical, Sinopharm Capital, Sherpa Healthcare Partners, and Hillhouse Ventures.